Mijia Lu

Title: Mijia Lu: Innovator in RNA Virus Research

Introduction

Mijia Lu is a prominent inventor based in Columbus, OH, known for his significant contributions to the field of RNA virus research. With a total of two patents to his name, he has made strides in developing methods and compositions for treating negative-sense single-stranded RNA viruses.

Latest Patents

Mijia Lu's latest patents include innovative methods for detecting modified adenosine in target RNA molecules. This patent outlines a method that involves contacting target RNA with an adenosine deaminase enzyme to generate a target RNA with deaminated adenosines, allowing for the detection of modified adenosine within a specific m6A motif. Another notable patent focuses on recombinant vectors encoding Zika virus protein subunits. This invention provides compositions and methods for producing recombinant vectors that encode Zika virus nonstructural protein 1, as well as envelope and premembrane proteins, aimed at inducing an immune response against Zika virus.

Career Highlights

Throughout his career, Mijia Lu has worked with esteemed institutions such as the University of Chicago and Nationwide Children's Hospital, Inc. His work has been pivotal in advancing the understanding and treatment of RNA viruses.

Collaborations

Mijia Lu has collaborated with notable colleagues, including Jianrong Li and Mark E Peeples, contributing to a rich exchange of ideas and research in the field.

Conclusion

Mijia Lu's innovative work in RNA virus research and his patents reflect his dedication to advancing medical science. His contributions are vital in the ongoing fight against viral infections, showcasing the importance of innovation in healthcare.